Skip to content

Montilet Tablet 10 mg

Storage: Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.

মন্টিলেট ট্যাবলেট Price Information

Per Piece

৳15.05

Per Strip

৳150.50

Per Pack

৳150.50

Pack Size

10's pack

Note: Prices may vary. Contact pharmacy for latest prices.

Description

Montilet Tablet is an essential respiratory medication containing Montelukast Sodium 10 mg. Manufactured by Amulet Pharmaceuticals Ltd, this tablet effectively manages asthma, allergic rhinitis, and exercise-induced bronchoconstriction. Priced at ৳15.05 per unit, it offers affordable therapy in a 10’s pack (৳150.50).

The drug works by blocking leukotriene receptors, reducing airway inflammation. Adults and adolescents (15+ years) take 10 mg daily, while children (6 months-14 years) require lower doses. Store below 30°C, away from light/moisture. Avoid combining with NSAIDs or sedatives without medical advice.

Common side effects include headache and digestive discomfort. Rare risks involve mood changes or liver issues. Pregnant/lactating women should use cautiously. Montilet is not for acute asthma attacks but prevents symptoms when taken nightly or 2 hours pre-exercise.

As a leukotriene receptor antagonist, it complements other asthma treatments. Explore similar Montelukast Sodium brands on Medexly for alternatives. Always consult doctors for dosage adjustments or persistent side effects.

Dosage & Administration

Adults: 10 mg once daily. Children (6-14 yrs): 5 mg, (6 months-5 yrs): 4 mg. Take at night for asthma/allergies, 2 hrs before exercise for EIB. Dosage adjustments needed for pediatric populations. Do not stop abruptly without medical advice.

Side Effects

Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.

Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.

Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.

Pregnancy & Lactation

Pregnancy Category B. Use only if benefits outweigh risks. Excreted in breast milk—consult doctor during lactation.

Precautions & Warnings

Not for acute asthma attacks. Monitor behavioral changes & liver enzymes periodically. Report any mood swings immediately.

Use in Special Populations

No dose adjustment needed for elderly. Hepatic impairment requires monitoring. Contraindicated below 6 months.

Overdose Effects

There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Montilet and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.

মন্টিলেট ট্যাবলেট Frequently Asked Questions

⚠️ Disclaimer

At Medexly, we're committed to providing reliable and accessible health information. Please note, however, that all content is for informational purposes only and not intended as medical advice. Our information is collected from pharmaceutical companies, the internet, public sources, and trusted references; therefore, errors or inaccuracies may occur. The information on our website is not legally binding. For personal medical care, always consult a qualified physician. Our goal is to support you with trustworthy information — not to replace the role of a doctor.

More Medicines From Amulet Pharmaceuticals Ltd

No other medicines found from this company.

বাংলাদেশের সর্বাধিক ব্যবহৃত ওষুধের তালিকা - জেনেরিক নাম, ব্র্যান্ড, ডোজ ফর্ম এবং ফার্মাসিউটিক্যাল কোম্পানির ভিত্তিতে